Comment by zadig

There is actually now a LOT of interest in the biomedical community for circulating tumor DNA - a quick Pubmed search yields 3317 results and Illumina is practically throwing money at the field. You have to keep in mind that the sequencing technology has only recently become cheap and sophisticated enough for this kind of highly sensitive testing to be possible.